Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Incyte and Merus Entered into Research Collaboration to Discover and Develop Bispecific Antibodies
Thursday, December 22, 2016Incyte Corporation and Merus NV announced that they have entered into a global strategic collaboration agreement focused on the research discovery and development of bispecific antibodies utilizing Merus proprietary Biclonics technology platform The...
X-Chem Entered into Multi-Target Drug Discovery Collaboration with Taiho Pharmaceutical
Wednesday, December 21, 2016XChem Inc a privately held biotechnology company focused on applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics today announced that it entered into a multitarget drug discovery collaboration wit...
Soligenix Advances Collaboration with IDT Biologika
Wednesday, December 21, 2016Soligenix Inc a latestage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need announced today that it has extended its collaboration with IDT Biologika hereafter ref...
Allergan to Acquire Acelity L.P. Inc.'s LifeCell Corporation for $2.9 Billion
Wednesday, December 21, 2016Allergan plc a leading global biopharmaceutical company and Acelity today announced that they have entered into a definitive agreement under which Allergan has agreed to acquire the regenerative medicine company LifeCell for billion in cash subject...
FDA Orphan Drug Designation Granted to Profounda Inc. for the treatment of Acanthamoeba Keratitis with miltefosine
Tuesday, December 20, 2016Profounda Inc Profounda announced that it has received the US Food and Drug Administrations FDA Orphan Drug Designation for the treatment of Acanthamoeba Keratitis with miltefosine Profounda licensed miltefosine Impavido from Knight Therapeutics USA...
CureDuchenne Ventures Invests in TRiNDS to Provide Clinical Trial Solutions for Neuromuscular Disorders
Tuesday, December 20, 2016CureDuchenne Ventures LLC a company that funds research to find a cure for Duchenne muscular dystrophy announced today that they invested in TRiNDS LLC a new contract research organization born from the Cooperative International Neuromuscular Researc...
Aurinia Pharmaceuticals Entered into Manufacturing Collaboration Agreement with Lonza for Voclosporin
Tuesday, December 20, 2016Aurinia Pharmaceuticals Inc a clinical stage biopharmaceutical company focused on the global immunology market today announced it has entered into a longterm agreement with Lonza for the manufacture of voclosporin active pharmaceutical ingredient API...
RegeneRx Receives Notice of Intent to Grant Patent in EU for Treating Neural Injury with Thymosin Beta 4
Monday, December 19, 2016RegeneRx Biopharmaceuticals Inc a clinicalstage drug development company focused on tissue protection repair and regeneration today announced that it has received notice of Intent to Grant a patent from the European Patent Office for treating neural...
Ionis Pharmaceuticals Earns $28 Million from AstraZeneca for a New Drug to Treat Cancer
Monday, December 19, 2016Ionis Pharmaceuticals Inc announced that it has earned million from AstraZeneca following AstraZenecas completion of INDsupporting studies and license of IONISKRASRx or AZD IONISKRASRx is a Generation antisense drug discovered by Ionis designed to...
bluebird bio and apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement
Friday, December 16, 2016bluebird bio Inc a clinicalstage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cellbased immunotherapies for cancer and apceth Biopharma GmbH wwwapcethcom the global innovator and leader i...
